Pharmagreen Biotech Inc.Pharmagreen Biotech Inc.Pharmagreen Biotech Inc.

Pharmagreen Biotech Inc.

No trades
See on Supercharts
Market capitalization
‪431.37 K‬USD
−0.0014USD
‪−568.78 K‬USD
‪3.00 K‬USD
‪578.91 M‬
Beta (1Y)
−0.48

About Pharmagreen Biotech Inc.

CEO
Peter Wojcik
Headquarters
Coquitlam
Founded
2007
ISIN
US71716C1099
FIGI
BBG000H1CL35
Pharmagreen Biotech, Inc. is a biotech sciences company with specialized products and services in the booming cannabis industry. The firm's products focus on manufacturing and marketing of cannabis products for medical and recreational markets. Its services include Good Manufacturing Practices (GMP) certification for its Tissue Culture facilities, Cold Storage of plantlets as well as Nurseries. The company was founded on November 26, 2007 and is headquartered in Coquitlam, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of PHBI is 0.0007 USD — it has decreased by 18.75% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on OTC exchange Pharmagreen Biotech Inc. stocks are traded under the ticker PHBI.
PHBI stock is 23.08% volatile and has beta coefficient of −0.48. Check out the list of the most volatile stocks — is Pharmagreen Biotech Inc. there?
Yes, you can track Pharmagreen Biotech Inc. financials in yearly and quarterly reports right on TradingView.
PHBI stock has fallen by 18.75% compared to the previous week, the month change is a 8.33% rise, over the last year Pharmagreen Biotech Inc. has showed a 83.79% decrease.
PHBI net income for the last quarter is ‪−144.85 K‬ USD, while the quarter before that showed ‪−178.51 K‬ USD of net income which accounts for 18.86% change. Track more Pharmagreen Biotech Inc. financial stats to get the full picture.
Today Pharmagreen Biotech Inc. has the market capitalization of ‪431.37 K‬, it has increased by 41.67% over the last week.
No, PHBI doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PHBI shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Pharmagreen Biotech Inc. stock right from TradingView charts — choose your broker and connect to your account.
PHBI reached its all-time high on Nov 21, 2012 with the price of 196.0000 USD, and its all-time low was 0.0003 USD and was reached on Oct 12, 2023.
See other stocks reaching their highest and lowest prices.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Pharmagreen Biotech Inc. technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Pharmagreen Biotech Inc. stock shows the sell signal. See more of Pharmagreen Biotech Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Pharmagreen Biotech Inc. EBITDA is ‪−365.30 K‬ USD, and current EBITDA margin is ‪−15.81 K‬%. See more stats in Pharmagreen Biotech Inc. financial statements.